Inducing intravesical hyperthermia of the ex-vivo porcine bladder wall: radiofrequency-induction versus recirculation using a custom-made device

References

• Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J, et al. Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer. 2013;49:1374–1403.
   PubMed Web of Science ®Google Scholar
• Antoni S, Ferlay J, Soerjomataram I, et al. Bladder cancer incidence and mortality: a global overview and recent trends. Eur Urol. 2017;71:96–108.
   PubMed Web of Science ®Google Scholar
• Dy GW, Gore JL, Forouzanfar MH, et al. Global burden of urologic cancers, 1990–2013. Eur Urol. 2017;71:437–446.
   PubMed Web of Science ®Google Scholar
• Cambier S, Sylvester RJ, Collette L, et al. EORTC nomograms and risk groups for predicting recurrence, progression, and disease-specific and overall survival in non-muscle-invasive stage Ta-T1 urothelial bladder cancer patients treated with 1–3 years of maintenance bacillus calmette-guerin. Eur Urol. 2016;69:e123–e129.
   PubMed Web of Science ®Google Scholar
• Babjuk M, Burger M, Compérat E, et al. EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2016. Eur Urol. 2017;71:e173–e161.
   PubMed Web of Science ®Google Scholar
• Lammers RJ, Witjes JA, Inman BA, et al. The role of a combined regimen with intravesical chemotherapy and hyperthermia in the management of non-muscle-invasive bladder cancer: a systematic review. Eur Urol. 2011;60:81–93.
   PubMed Web of Science ®Google Scholar
• van Valenberg H, Colombo R, Witjes F. Intravesical radiofrequency-induced hyperthermia combined with chemotherapy for non-muscle-invasive bladder cancer. Int J Hyperthermia. 2016;32:351–362.
   PubMed Web of Science ®Google Scholar
• Arends TJ, Nativ O, Maffezzini M, et al. Results of a randomised controlled trial comparing intravesical chemohyperthermia with mitomycin C versus bacillus calmette-guerin for adjuvant treatment of patients with intermediate- and high-risk non-muscle-invasive bladder cancer. Eur Urol. 2016;69:1046–1052.
   PubMed Web of Science ®Google Scholar
• Sousa A, Inman BA, Pineiro I, et al. A clinical trial of neoadjuvant hyperthermic intravesical chemotherapy (HIVEC) for treating intermediate and high-risk non-muscle invasive bladder cancer. Int J Hyperthermia. 2014;30:166–170.
   PubMed Web of Science ®Google Scholar
• Sousa A, Pineiro I, Rodriguez S, et al. Recirculant hyperthermic IntraVEsical chemotherapy (HIVEC) in intermediate-high-risk non-muscle-invasive bladder cancer. Int J Hyperthermia. 2016;32:374–380.
   PubMed Web of Science ®Google Scholar
• Soria F, Milla P, Fiorito C, et al. Efficacy and safety of a new device for intravesical thermochemotherapy in non-grade 3 BCG recurrent NMIBC: a phase I-II study. World J Urol. 2016;34:189–195.
   PubMed Web of Science ®Google Scholar
• Ekin RG, Akarken I, Cakmak O, et al. Results of intravesical chemo-hyperthermia in high-risk non-muscle invasive bladder cancer. Asian Pac J Cancer Prev. 2015;16:3241–3245.
   PubMedGoogle Scholar
• Ekin RG, Akarken I, Zorlu F, et al. Intravesical bacillus calmette-guerin versus chemohyperthermia for high-risk non-muscle-invasive bladder cancer. CUAJ. 2015;9:278–283.
   Google Scholar
• Overgaard J. Combined adriamycin and hyperthermia treatment of a murine mammary carcinoma in vivo. Cancer Res. 1976;36:3077–3081.
   PubMed Web of Science ®Google Scholar
• Rampersaud EN, Vujaskovic Z, Inman BA. Hyperthermia as a treatment for bladder cancer. Oncology (Williston Park, N.Y.). 2010;24:1149–1155.
   PubMed Web of Science ®Google Scholar
• Vukomanovic I, Colovic V, Soldatovic I, et al. Prognostic significance of tumor location in high-grade non-muscle-invasive bladder cancer. Med Oncol. 2012;29:1916–1920.
   PubMed Web of Science ®Google Scholar
• Brooks M, Mo Q, Krasnow R, et al. Positive association of collagen type I with non-muscle invasive bladder cancer progression. Oncotarget. 2016;7:82609–82619.
   PubMedGoogle Scholar
• Kneidl B, Peller M, Winter G, et al. Thermosensitive liposomal drug delivery systems: state of the art review. Int J Nanomedicine. 2014;9:4387–4398.
   PubMed Web of Science ®Google Scholar
• May JP, Li SD. Hyperthermia-induced drug targeting. Expert Opin Drug Deliv. 2013;10:511–527.
   PubMed Web of Science ®Google Scholar
• Wallner KE, Banda M, Li GC. Hyperthermic enhancement of cell killing by mitomycin C in mitomycin C-resistant Chinese hamster ovary cells. Cancer Res. 1987;47:1308–1312.
   PubMed Web of Science ®Google Scholar
• Uchibayashi T, Lee SW, Kunimi K, et al. Studies of effects of anticancer agents in combination with/without hyperthermia on metastasized human bladder cancer cells in chick embryos using the polymerase chain reaction technique. Cancer Chemother Pharmacol. 1994;35:S84–S87.
   PubMedGoogle Scholar
• Tan WS, Palou J JK. Safety and tolerability analysis of hyperthermic intravesical mitomycin to mitomycin alone in HIVEC I and HIVEC II: an interim analysis of 307 patients. Eur Urol Suppl. 2017;16:e1150. Conference Abstract.
   Google Scholar
• Bruners P, Hodenius M, Gunther RW, et al. Flussigkeitsmodulierte RF-Ablation: In-vitro-Experimente [Fluid-modulated RF ablation: in-vitro experiments]. Rofo. 2007;179:380–386. German.
   PubMedGoogle Scholar
• Provenzano DA, Watson TW, Somers DL. The interaction between the composition of preinjected fluids and duration of radiofrequency on lesion size. Reg Anesth Pain Med. 2015;40:112–124.
   PubMed Web of Science ®Google Scholar
• Lara NC, Haider AA, Ho JC, et al. Water-structuring molecules and nanomaterials enhance radiofrequency heating in biologically relevant solutions. Chem Commun. 2016;52:12630–12633.
   PubMed Web of Science ®Google Scholar
• Rath-Wolfson L, Moskovitz B, Dekel Y, et al. Combined intravesical hyperthermia and mitomycin chemotherapy: a preliminary in vivo study. Int J Exp Pathol. 2003;84:145–152.
   PubMed Web of Science ®Google Scholar
• Brousell SC, Longo TA, Fantony JJ, et al. Heat-targeted drug delivery using the Combat BRS device for treating bladder cancer. J Urol. 2017;197:e855. Conference Abstract.
   Web of Science ®Google Scholar
• van Valenberg FJP, van der Heijden AG, Lammers RJM, et al. Intravesical radiofrequency induced hyperthermia enhances mitomycin C accumulation in tumour tissue. Int J Hyperthermia. 2017;1–6.
   Web of Science ®Google Scholar